Brief: Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (Saa) Report For Qixleef™
02/09/2021 11:58
Sept 2 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* TETRA BIO-PHARMA RECEIVES POSITIVE SCIENTIFIC ADVICE
ASSESSMENT
(SAA) REPORT FOR QIXLEEF™
* TETRA BIO PHARMA INC - SAA REPORT ENDORSED TETRA
BIO-PHARMA'S
PROPOSED NONCLINICAL DEVELOPMENT AND QUALITY PROGRAMS FOR
QIXLEEF
Source text for Eikon: ID:nCNWzKfgTa
Further company coverage: TBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding